Gross total resection in low-grade and pretreated high-grade invasive growth hormone pituitary adenomas promises favorable outcomes

Abstract Introduction Growth hormone (GH)-secreting pituitary tumors cause serious systemic comorbidities, necessitating the achievement of gross total resection (GTR) and biochemical remission. This study aims to identify predictors of resection status and biochemical remission. Methods We retrospe...

Full description

Saved in:
Bibliographic Details
Main Authors: Ting-Wei Chang, Chun-Chia Tseng, Yu-Chi Wang, Yin-Cheng Huang, Peng-Wei Hsu, Chi-Cheng Chuang, Cheng-Chi Lee
Format: Article
Language:English
Published: Springer 2025-08-01
Series:Discover Oncology
Subjects:
Online Access:https://doi.org/10.1007/s12672-025-03313-5
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Introduction Growth hormone (GH)-secreting pituitary tumors cause serious systemic comorbidities, necessitating the achievement of gross total resection (GTR) and biochemical remission. This study aims to identify predictors of resection status and biochemical remission. Methods We retrospectively reviewed the records of 54 GH adenoma patients receiving endoscopic endonasal transsphenoidal approach (EETSA). Medical records and magnetic resonance imaging were reviewed for tumor size, volume, resection status, invasion status, and Knosp and Hardy–Wilson grades. We also classified invasion status into high- and low-grade groups. Biochemical remission was defined as an insulin-like growth factor 1 value within sex- and age-adjusted reference or a random GH level < 1.0 ng/mL. Results The degrees of horizontal and vertical invasion based on preoperative Knosp and Hardy–Wilson grade were highly associated with intraoperative resection status (p = 0.0054, 0.0043 and 0.013 respectively). We also found more significant differences between resection status and higher-grade invasion (p = 0.0018, 0.006 and 0.0018, respectively). Hardy–Wilson grades and resection status were significantly associated with biochemical remission (p = 0.0484, 0.0252, and 0.0007, respectively). Although we observed no difference between outcomes with respect to micro- vs. macroadenoma, tumor size and volume were significantly associated with outcomes (p = 0.017, 0.0032, respectively). More significant differences were observed between biochemical remission and higher-grade Hardy–Wilson invasion grade (p = 0.0053 and 0.0075). Multivariate analysis showed that higher-grade Hardy–Wilson invasion correlated with resection status (p = 0.0481 and 0.0125); only resection status was associated with biochemical remission (p = 0.0101). Conclusions EETSA remains the best treatment option for GH adenomas. Biochemical remission was highly associated with invasion status and the possibility of achieving GTR. Aggressive resection for low-grade and pretreated high-grade tumors promises favorable outcomes.
ISSN:2730-6011